Sanofi says biotech acquisitions will help overcome diabetes declineSanofi has just spent $16 billion on acquiring Bioverativ and Ablynx – and yesterday’s Q4 results revealed why Share XSanofi says biotech acquisitions will help overcome diabetes declinehttps://pharmaphorum.com/news/sanofi-says-biotech-acquisitions-will-help-overcome-diabetes-decline/
